| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.027 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.025 | 0.9 |